
Victor A. Mandala
Examiner (ID: 4013)
| Most Active Art Unit | 2899 |
| Art Unit(s) | 2826, 2899 |
| Total Applications | 2147 |
| Issued Applications | 1940 |
| Pending Applications | 98 |
| Abandoned Applications | 137 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 20050208
[patent_doc_number] => 20250188430
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-06-12
[patent_title] => PFU DNA POLYMERASE MUTANTS WITH REVERSE TRANSCRIPTASE ACTIVITY AND THEIR APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 19/014260
[patent_app_country] => US
[patent_app_date] => 2025-01-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 2269
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 19014260
[rel_patent_id] =>[rel_patent_doc_number] =>) 19/014260 | Pfu DNA polymerase mutants with reverse transcriptase activity and their applications | Jan 8, 2025 | Issued |
Array
(
[id] => 19601387
[patent_doc_number] => 20240392267
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-28
[patent_title] => Taq DNA Polymerase Mutants for Probe qPCR
[patent_app_type] => utility
[patent_app_number] => 18/780632
[patent_app_country] => US
[patent_app_date] => 2024-07-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4231
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 301
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18780632
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/780632 | Taq DNA Polymerase Mutants for Probe qPCR | Jul 22, 2024 | Pending |
Array
(
[id] => 19556861
[patent_doc_number] => 20240368653
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-07
[patent_title] => MODIFIED ss-GALACTOSIDASE
[patent_app_type] => utility
[patent_app_number] => 18/776771
[patent_app_country] => US
[patent_app_date] => 2024-07-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 33876
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 235
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18776771
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/776771 | MODIFIED ss-GALACTOSIDASE | Jul 17, 2024 | Pending |
Array
(
[id] => 19479765
[patent_doc_number] => 20240327807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-03
[patent_title] => High Throughput Reaction Assembly
[patent_app_type] => utility
[patent_app_number] => 18/742500
[patent_app_country] => US
[patent_app_date] => 2024-06-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6536
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 164
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18742500
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/742500 | High throughput reaction assembly | Jun 12, 2024 | Issued |
Array
(
[id] => 19643181
[patent_doc_number] => 20240417701
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-12-19
[patent_title] => Method For Improving Mitochondrial Functions
[patent_app_type] => utility
[patent_app_number] => 18/740839
[patent_app_country] => US
[patent_app_date] => 2024-06-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 11719
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18740839
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/740839 | Method For Improving Mitochondrial Functions | Jun 11, 2024 | Pending |
Array
(
[id] => 20179799
[patent_doc_number] => 20250263757
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-08-21
[patent_title] => METHODS OF USING SYNTROPHUS ACIDITROPHICUS TO PRODUCE CYCLOHEXANE-1-CARBOXYLATE (CHC)
[patent_app_type] => utility
[patent_app_number] => 18/998009
[patent_app_country] => US
[patent_app_date] => 2024-06-11
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5326
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -22
[patent_words_short_claim] => 109
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18998009
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/998009 | METHODS OF USING SYNTROPHUS ACIDITROPHICUS TO PRODUCE CYCLOHEXANE-1-CARBOXYLATE (CHC) | Jun 10, 2024 | Pending |
Array
(
[id] => 19572156
[patent_doc_number] => 20240376448
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-11-14
[patent_title] => ENGINEERED RNA POLYMERASE VARIANTS
[patent_app_type] => utility
[patent_app_number] => 18/661523
[patent_app_country] => US
[patent_app_date] => 2024-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 56048
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -50
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18661523
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/661523 | ENGINEERED RNA POLYMERASE VARIANTS | May 9, 2024 | Pending |
Array
(
[id] => 20108468
[patent_doc_number] => 12359177
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-07-15
[patent_title] => DNA polymerase mutant suited to nucleic acid amplification from RNA
[patent_app_type] => utility
[patent_app_number] => 18/660667
[patent_app_country] => US
[patent_app_date] => 2024-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7949
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 153
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660667
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/660667 | DNA polymerase mutant suited to nucleic acid amplification from RNA | May 9, 2024 | Issued |
Array
(
[id] => 19432987
[patent_doc_number] => 20240301485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-12
[patent_title] => Compositions and Analysis of Dephosphorylated Oligoribonucleotides
[patent_app_type] => utility
[patent_app_number] => 18/660998
[patent_app_country] => US
[patent_app_date] => 2024-05-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 35899
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18660998
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/660998 | Compositions and Analysis of Dephosphorylated Oligoribonucleotides | May 9, 2024 | Pending |
Array
(
[id] => 19418763
[patent_doc_number] => 20240294886
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => POLYMERASE MUTANTS AND USE WITH 3'-OH UNBLOCKED REVERSIBLE TERMINATORS
[patent_app_type] => utility
[patent_app_number] => 18/652554
[patent_app_country] => US
[patent_app_date] => 2024-05-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14615
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 97
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18652554
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/652554 | POLYMERASE MUTANTS AND USE WITH 3'-OH UNBLOCKED REVERSIBLE TERMINATORS | Apr 30, 2024 | Pending |
Array
(
[id] => 19403971
[patent_doc_number] => 20240287482
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => ENGINEERED POLYMERASES WITH REDUCED SEQUENCE-SPECIFIC ERRORS
[patent_app_type] => utility
[patent_app_number] => 18/650856
[patent_app_country] => US
[patent_app_date] => 2024-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 71856
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 62
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18650856
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/650856 | ENGINEERED POLYMERASES WITH REDUCED SEQUENCE-SPECIFIC ERRORS | Apr 29, 2024 | Pending |
Array
(
[id] => 20144204
[patent_doc_number] => 12378535
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-08-05
[patent_title] => Engineered glucosyltransferases
[patent_app_type] => utility
[patent_app_number] => 18/628140
[patent_app_country] => US
[patent_app_date] => 2024-04-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 18030
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 142
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18628140
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/628140 | Engineered glucosyltransferases | Apr 4, 2024 | Issued |
Array
(
[id] => 19361165
[patent_doc_number] => 20240263199
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-08
[patent_title] => Method for Improving Production of L-lactic Acid by Saccharomyces Cerevisiae Based on Regulation and Control of Ethanol Metabolic Flux
[patent_app_type] => utility
[patent_app_number] => 18/604597
[patent_app_country] => US
[patent_app_date] => 2024-03-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3777
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -4
[patent_words_short_claim] => 162
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18604597
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/604597 | Method for Improving Production of L-lactic Acid by Saccharomyces Cerevisiae Based on Regulation and Control of Ethanol Metabolic Flux | Mar 13, 2024 | Pending |
Array
(
[id] => 20220125
[patent_doc_number] => 20250283056
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-09-11
[patent_title] => MODIFIED O-METHYLTRANSFERASES USEFUL FOR PRODUCTION OF O-METHYLATED PHENOLIC NATURAL PRODUCTS
[patent_app_type] => utility
[patent_app_number] => 18/600046
[patent_app_country] => US
[patent_app_date] => 2024-03-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16809
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18600046
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/600046 | MODIFIED O-METHYLTRANSFERASES USEFUL FOR PRODUCTION OF O-METHYLATED PHENOLIC NATURAL PRODUCTS | Mar 7, 2024 | Pending |
Array
(
[id] => 19512360
[patent_doc_number] => 20240344046
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-10-17
[patent_title] => RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME
[patent_app_type] => utility
[patent_app_number] => 18/597204
[patent_app_country] => US
[patent_app_date] => 2024-03-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 32834
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18597204
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/597204 | RECOMBINANT HUMAN SIALIDASES, SIALIDASE FUSION PROTEINS, AND METHODS OF USING THE SAME | Mar 5, 2024 | Pending |
Array
(
[id] => 19403974
[patent_doc_number] => 20240287485
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-08-29
[patent_title] => MODIFIED ENZYMES
[patent_app_type] => utility
[patent_app_number] => 18/596176
[patent_app_country] => US
[patent_app_date] => 2024-03-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46554
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18596176
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/596176 | MODIFIED ENZYMES | Mar 4, 2024 | Pending |
Array
(
[id] => 19693276
[patent_doc_number] => 20250011821
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-01-09
[patent_title] => USE OF TYPE III POLYKETIDE SYNTHASES FROM BACTERIA AS PHLOROGLUCINOL SYNTHASES
[patent_app_type] => utility
[patent_app_number] => 18/591697
[patent_app_country] => US
[patent_app_date] => 2024-02-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9055
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18591697
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/591697 | USE OF TYPE III POLYKETIDE SYNTHASES FROM BACTERIA AS PHLOROGLUCINOL SYNTHASES | Feb 28, 2024 | Pending |
Array
(
[id] => 19418828
[patent_doc_number] => 20240294951
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-09-05
[patent_title] => GLYCEROL FREE ETHANOL PRODUCTION
[patent_app_type] => utility
[patent_app_number] => 18/590712
[patent_app_country] => US
[patent_app_date] => 2024-02-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13095
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18590712
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/590712 | GLYCEROL FREE ETHANOL PRODUCTION | Feb 27, 2024 | Pending |
Array
(
[id] => 19754692
[patent_doc_number] => 20250043257
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2025-02-06
[patent_title] => NOVEL CRISPR-ASSOCIATED (CAS) PROTEIN
[patent_app_type] => utility
[patent_app_number] => 18/435579
[patent_app_country] => US
[patent_app_date] => 2024-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 46336
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18435579
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/435579 | NOVEL CRISPR-ASSOCIATED (CAS) PROTEIN | Feb 6, 2024 | Abandoned |
Array
(
[id] => 19265639
[patent_doc_number] => 20240209338
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2024-06-27
[patent_title] => EVOLUTION OF CYTIDINE DEAMINASES
[patent_app_type] => utility
[patent_app_number] => 18/419414
[patent_app_country] => US
[patent_app_date] => 2024-01-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 22854
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -42
[patent_words_short_claim] => 64
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 18419414
[rel_patent_id] =>[rel_patent_doc_number] =>) 18/419414 | EVOLUTION OF CYTIDINE DEAMINASES | Jan 21, 2024 | Pending |